Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sthephanie Estrada"'
Autor:
Yamixa Delgado, Anamaris Torres-Sanchez, Daraishka Perez, Grace Torres, Sthephanie Estrada, Natalia Ortiz Alvelo, Jaisy Vega, Laurie Santos, Aracelis Torres, Bismark A. Madera, Yancy Ferrer-Acosta
Publikováno v:
Biomedicines, Vol 12, Iss 10, p 2272 (2024)
Clinically approved iron chelators, originally designed to address iron overload disorders, have emerged as potential anticancer agents. Deferasirox (Def), a tridentate iron chelator, has demonstrated antiproliferative effects in cancer. Background/O
Externí odkaz:
https://doaj.org/article/7fbb3c07a44c4b76959f64fe22927e3f
Autor:
Anamaris Torres-Sanchez, Grace Torres, Sthephanie Estrada, Daraishka Perez, Carlos Garcia, Melissa Milian, Eddian Velazquez, Valerie Molina, Yamixa Delgado
Publikováno v:
Pharmaceuticals, Vol 17, Iss 6, p 694 (2024)
Recently, there has been great interest in plant-derived compounds known as phytochemicals. The pentacyclic oleanane-, ursane-, and lupane-type triterpenes are phytochemicals that exert significant activity against diseases like cancer. Lung cancer i
Externí odkaz:
https://doaj.org/article/5e3e6bbf51004b3cb686689571998146
Autor:
Zally Torres-Martinez, Daraishka Pérez, Grace Torres, Sthephanie Estrada, Clarissa Correa, Natasha Mederos, Kimberly Velazquez, Betzaida Castillo, Kai Griebenow, Yamixa Delgado
Publikováno v:
BioTech, Vol 12, Iss 1, p 13 (2023)
Nanosized drug delivery systems (DDS) have been studied as a novel strategy against cancer due to their potential to simultaneously decrease drug inactivation and systemic toxicity and increase passive and/or active drug accumulation within the tumor
Externí odkaz:
https://doaj.org/article/2d1c01b939b84995a3399d63aa30b6de
Autor:
Natalia I. Ortiz Alvelo, Grace Torres, Sthephanie Estrada, Daraishka Pérez, Yancy Ferrer, Yamixa Delgado
Publikováno v:
Cancer Research. 83:3898-3898
Lung cancer is the second most common and leading cause of cancer-related deaths worldwide with 85% of these cases being non-small cell lung carcinoma (NSCLC). Unfortunately, despite improvements in NSCLC outcomes, many of these tumors develop resist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30e145bd22c6bb006bd8dc4752734931
https://doi.org/10.1158/1538-7445.am2023-3898
https://doi.org/10.1158/1538-7445.am2023-3898